PFE News and Press, Pfizer Inc. From 06/23/24

2024-06-23 14:00:00 ET More on Eli Lilly, Novo Nordisk Eli Lilly: The Party Is Probably Nearing The End Novo Nordisk: Leading The Fight Against Diabetes And Obesity SA Asks: Who will launch the next big weight-loss drug? SA Asks: Is Eli Lilly or Novo No...

2024-06-23 12:49:01 ET More on the markets SPY: The Upside Is Likely Capped SPY: Rating Downgrade Due To Overvaluation Perfect Time For November Election Protection S&P posts three-week win streak, but momentum stalls after hitting 5,500 points mark ...

2024-06-23 11:13:33 ET Summary Since the publication of my last article, Pfizer has continued to surprise me pleasantly. In early May, Pfizer published financial results for the first quarter of 2024, which were enthusiastically received by Wall Street. On June 14, 2024, the c...

2024-06-23 05:42:00 ET Would you like to widen the stream of passive income you can expect each year? Managing rental property is an option, but most retirees find this method less passive than they would like it to be. Investors who are attracted to truly passive income generation may ...

2024-06-22 09:30:00 ET Summary We go over the importance of a DGI portfolio for income investors and retirees. We outline a simple process of selecting 15-20 individual dividend stocks for long-term growth, income, and lower volatility. In the end, we present a 15-stock DGI po...

2024-06-22 06:03:00 ET Investors looking for high-yield dividend stocks to buy now should turn their attention toward the healthcare sector: Three relatively reliable drugmakers are trading near their 52-week lows. Their stock prices may have been beaten down, but it's more than likely ...

2024-06-21 16:51:47 ET Summary Schwab U.S. Dividend Equity ETF™ is a conservative fund that offers stable growth and dividend growth, not suitable for high-growth or high-yield investors. It is too boring for you. The SCHD ETF holds 103 diversified holdings, with the top se...

2024-06-20 23:47:38 ET Summary Nektar Therapeutics has two Phase IIb studies underway for rezpeg in atopic dermatitis and severe alopecia areata, with read-outs expected in 1H'25. Success in either indication would significantly boost Nektar's prospects (and share price), but Phas...

2024-06-20 09:00:00 ET Summary This week, I added to my positions in CSCO, PFE, and UTF. In the 2nd week of June, the Dividend Harvesting Portfolio generated $21.73 of dividend income. The Dividend Harvesting Portfolio has already generated 65.31% of the total dividend income ...

2024-06-20 08:46:01 ET USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – This year’s 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without increasing hope for...